In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decline. At the time of writing, the benchmark index is down 0.1% to 7,447.7 points.
Four ASX shares that have not let that hold them back are listed below. Here’s why they are charging higher:
AGL Energy Limited (ASX: AGL)
The AGL Energy share price is up 8% to $6.80. Investors have been buying this energy company’s shares after they were upgraded by analysts at Credit Suisse. According to the note, the broker has upgraded the AGL shares to an outperform with a lofty price target of $8.50.
Genetic Signatures Ltd (ASX: GSS)
The Genetic Signatures share price is up 5% to $1.75. This morning the diagnostics company announced that the Therapeutic Goods Administration has registered a saliva-based protocol to collect and test patients for COVID-19 using its flagship 3base EasyScreen SARS-CoV-2 (COVID-19) Detection Kit. Management believes this style of collection will be particularly helpful with Omicron strain.
Liontown Resources Limited (ASX: LTR)
The Liontown Resources share price is up 2% to $1.57. This follows news that the lithium developer has awarded a key contract to Metso-Outotec for the design, fabrication, and delivery of a Semi Autogenous Grinding (SAG) Mill for its flagship Kathleen Valley Lithium Project in Western Australia. Management notes that this puts it on course to achieve its target of first production of lithium concentrate in 2024.
Novonix Ltd (ASX: NVX)
The Novonix share price has jumped 11% to $10.38. This morning the battery materials company announced plans for a secondary listing on the Nasdaq index on Wall Street. Novonix hopes that listing on the famous stock exchange will allow US investor and fund managers the opportunity to invest in the growing company.
The post Why AGL, Genetic Signatures, Liontown, and Novonix shares are charging higher appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of August 16th 2021
- Genetic Signatures (ASX:GSS) share price leaps 6% on COVID test news
- Here’s why the AGL (ASX:AGL) share price is surging 8% today
- ASX 200 (ASX:XJO) midday update: AGL and Novonix shares shoot higher
- Novonix (ASX:NVX) share price jumps 7% on Nasdaq listing plans
- Buying ASX shares in 2022? Here’s what you need to know: expert
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3ncIVEt